Evidence map›Paper›PMID 37269181›Full record

ArticleHuman brain mapping2023

Network connectivity and structural correlates of survival in progressive supranuclear palsy and corticobasal syndrome.

David J Whiteside, Duncan Street, Alexander G Murley, P Simon Jones, Maura Malpetti, Boyd C P Ghosh, Ian Coyle-Gilchrist, Alexander Gerhard, Michele T Hu, Johannes C Klein and 6 more

Open access · goldAbstract read
In one paragraph

Article in Human brain mapping, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Prognostic factors of survival in corticobasal syndrome and corticobasal degeneration: A scoping review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  3. Review
  4. Brain Networks Route Neurodegeneration Patterns in Patients with Progressive Supranuclear Palsy.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Pathomechanisms of cognitive and behavioral impairment in corticobasal degeneration.Journal of neural transmission (Vienna, Austria : 1996) · 2023
    Review
  11. Aging, NRF2, and TAU: A Perfect Match for Neurodegeneration?Antioxidants (Basel, Switzerland) · 2023
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 2 countries.

David J WhitesideDepartment of Clinical Neurosciences and Cambridge Centre for Parkinson-plus, University of Cambridge, Cambridge, UK.ORCID 0000-0002-5890-9220
Duncan StreetDepartment of Clinical Neurosciences and Cambridge Centre for Parkinson-plus, University of Cambridge, Cambridge, UK.
Alexander G MurleyDepartment of Clinical Neurosciences and Cambridge Centre for Parkinson-plus, University of Cambridge, Cambridge, UK.
P Simon JonesDepartment of Clinical Neurosciences and Cambridge Centre for Parkinson-plus, University of Cambridge, Cambridge, UK.
Maura MalpettiDepartment of Clinical Neurosciences and Cambridge Centre for Parkinson-plus, University of Cambridge, Cambridge, UK.
Boyd C P GhoshWessex Neurological Centre, University Hospital Southampton, Southampton, UK.
Ian Coyle-GilchristNorfolk and Norwich University Hospital, Norwich, UK.
Alexander GerhardDivision of Neuroscience and Experimental Psychology, Wolfson Molecular Imaging Centre, University of Manchester, Manchester, UK.
Michele T HuOxford Parkinson's Disease Centre and Division of Neurology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Johannes C KleinOxford Parkinson's Disease Centre and Division of Neurology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.ORCID 0000-0002-8553-2801
P Nigel LeighDepartment of Neuroscience, Brighton and Sussex Medical School, Brighton, UK.
Alistair ChurchDepartment of Neurology, Royal Gwent Hospital, Newport, UK.
David J BurnFaculty of Medical Sciences, Newcastle University, Newcastle, UK.
Huw R MorrisDepartment of Clinical and Movement Neurosciences, University College London, Queen Square Institute of Neurology, London, UK.
James B RoweDepartment of Clinical Neurosciences and Cambridge Centre for Parkinson-plus, University of Cambridge, Cambridge, UK.
Timothy RittmanDepartment of Clinical Neurosciences and Cambridge Centre for Parkinson-plus, University of Cambridge, Cambridge, UK.
University of Cambridge · GBNuffield Orthopaedic Centre · GBBrighton and Sussex Medical School · GBMRC Cognition and Brain Sciences Unit · GBNewcastle University · GBNorfolk and Norwich University Hospital · GBQueen Mary University of London · GBRoyal Gwent Hospital · GBUniversity Hospital Southampton NHS Foundation Trust · GBUniversity of Manchester · GB

Funding

Medical Research Council MC_UU_00030/14Medical Research Council MR/T033371/1Wellcome TrustWellcome Trust 220258
6 · The paper itself

Abstract

There is a pressing need to understand the factors that predict prognosis in progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS), with high heterogeneity over the poor average survival. We test the hypothesis that the magnitude and distribution of connectivity changes in PSP and CBS predict the rate of progression and survival time, using datasets from the Cambridge Centre for Parkinson-plus and the UK National PSP Research Network (PROSPECT-MR). Resting-state functional MRI images were available from 146 participants with PSP, 82 participants with CBS, and 90 healthy controls. Large-scale networks were identified through independent component analyses, with correlations taken between component time series. Independent component analysis was also used to select between-network connectivity components to compare with baseline clinical severity, longitudinal rate of change in severity, and survival. Transdiagnostic survival predictors were identified using partial least squares regression for Cox models, with connectivity compared to patients' demographics, structural imaging, and clinical scores using five-fold cross-validation. In PSP and CBS, between-network connectivity components were identified that differed from controls, were associated with disease severity, and were related to survival and rate of change in clinical severity. A transdiagnostic component predicted survival beyond demographic and motion metrics but with lower accuracy than an optimal model that included the clinical and structural imaging measures. Cortical atrophy enhanced the connectivity changes that were most predictive of survival. Between-network connectivity is associated with variability in prognosis in PSP and CBS but does not improve predictive accuracy beyond clinical and structural imaging metrics.

Indexed as

Corticobasal DegenerationNeurodegenerative DiseasesSupranuclear Palsy, ProgressiveHumansPrognosisconnectivitycorticobasal syndromefMRIpredictionprogressive supranuclear palsysurvivaltauopathies

Identifiers

PMID37269181
PMCPMC10318264
OpenAlexW4379197734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.